New Study Finds Heroin-Positive Patients Have Increasing Co-Occurrence of Non-Prescribed Fentanyl

The study demonstrates evidence of an escalating national epidemic

SAN DIEGO Sept. 20, 2017 – A new study examined urine drug test (UDT) results to measure the co-occurrence of non-prescribed fentanyl in populations of heroin-positive healthcare patients across the United States. The study revealed a 3,000 percent increase of non-prescribed fentanyl in heroin-positive patients between January 2013 and January 2017. Regionally, 5 of the 9 U.S. Census regions exhibited a dramatic increase in the co-occurrence of fentanyl use in the heroin-positive population, with New England exhibiting the greatest jump climbing from 3 percent to 76 percent. Read more

Millennium Health Announces Eugene I. Davis as Chairman of the Board and Jennifer Strickland as Chief Executive Officer

Planned transition of Ronald A. Rittenmeyer takes effect immediately

SAN DIEGO August 31, 2017 – Millennium Health, a leading health solutions company, is pleased to announce the appointment of Eugene I. Davis as Chairman of the Board and Jennifer Strickland, PharmD, BCPS, as Chief Executive Officer and Board Member. As part of a planned transition, Ronald A. Rittenmeyer steps down as Chairman and CEO and will serve in an advisory role through the end of the year.

Read more

New Study Finds One-Third of Patients Experience Uncontrolled Postoperative Pain

The study will be presented at the 12th Annual Perioperative Medicine Summit in Fort Lauderdale, FL, March 8-11

SAN DIEGO March 8, 2017 – An abstract and poster publication of a study from Millennium Health, a leading health solutions company, measured the incidence of uncontrolled postoperative pain in the inpatient setting. The study found that approximately 33 percent of patients were treated with injectable opioids for uncontrolled postoperative pain, varying within a range of 26 to 76 percent based on type of surgery.

Read more

Millennium Health Adds Levorphanol to its Medication Monitoring Menu

SAN DIEGO Dec. 12, 2016 – Millennium Health, a leading health solutions company, announced today the availability of a new definitive urine drug test for detecting the opioid medication levorphanol using LC-MS/MS technology. The addition is in response to requests from clinicians who prescribe levorphanol and want to include urine drug monitoring as part of a comprehensive treatment plan. Read more

New Study Supports Definitive Drug Testing To Enhance Substance Use Disorders Treatment

SAN DIEGO Nov. 17, 2016 – Millennium Health, a leading health solutions company, and Brightpoint Health, a nonprofit medical and mental health care provider, announced the publication of a new study that suggests medically necessary medication monitoring definitive drug testing using Liquid Chromatography with Tandem Mass Spectrometry (LC-MS/MS), can help clinicians enhance treatment outcomes in Substance Use Disorders (SUDs). The study was published in the “Journal of Addiction Medicine.” Read more

Ron Rittenmeyer Named to 10th Annual NACD Directorship 100

Leading F500 Directors and Governance Experts to be recognized in NYC on Nov. 30

PLANO, TX – August 2, 2016 – Millennium Health Chairman of the Board and Chief Executive Officer Ron Rittenmeyer has been named to The National Association of Corporate Directors’ (NACD) 2016 Directorship 100 list, a distinguished honor that annually recognizes the most influential leaders in the boardroom and corporate governance community.

Read more

Millennium Health Appoints Joan B. Stafslien and Jeffrey D. Goldberg to Board of Directors

Seasoned executives provide decades of health care experience

SAN DIEGO – Aug. 1, 2016 – Millennium Health, a leading health solutions company, today announced the appointment of Joan B. Stafslien and Jeffrey D. Goldberg to its Board of Directors.  Stafslien and Goldberg join current members Eugene I. Davis, Stephen Gray, and Chairman of the Board and Chief Executive Officer Ron Rittenmeyer. Read more